Breast Cancer Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Breast Cancer (Invasive, Non-Invasive (in Situ)), By Diagnosis (Blood Tests, Mammogram, Breast MRI, Breast Ultrasound, Breast Biopsy, Others), By Treatment (Breast Cancer Surgery, Radiation Therapy, Chemotherapy, Hormone Therapy, Targeted Therapy, Supportive/ Palliative Care), And By Geography - Forecasts From 2019 To 2024

The breast cancer treatment market is projected to grow at a CAGR of 3.01% to reach US$15.82 billion by 2024. The breast cancer treatment market is expected to grow at a moderate pace during the forecast period due to the worldwide prevalence of breast cancer. The main reasons for the disease include the consumption of alcohol and greater birth weight. The growing adoption of unhealthy lifestyle conditions among women of different age groups is leading to higher incidences of cancer during the forecast period. Breast cancer survival rates vary greatly worldwide, ranging from 80% or more in the North American region, Sweden and Japan to around 60% in the middle-income countries and below 40% in low-income countries (Source: WHO). Growing awareness regarding self-care and self-management, technological advancements, and R&D expenditure is further driving the market growth during the forecast period. Currently, available treatment includes medications, therapy devices, and technologies in addition to palliative or supportive care. However, the high cost of treatment may restrain the market growth during the forecast period.

Major industry players profiled as part of the report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., and IceCure Medical, Inc.

Breast Cancer Treatment Market Scope:

Report Metric	Details
Market size value in 2024	US$15.82 billion
Growth Rate	CAGR of 3.01% from 2018 to 2024
Base year	2018
Forecast period	2019–2024
Forecast Unit (Value)	USD Billion
Segments covered	Type, Diagnosis, Treatment, And Geography
Regions covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies covered	Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., IceCure Medical, Inc.
Customization scope	Free report customization with purchase

 

Segmentation

The breast cancer treatment market has been analyzed through the following segments:

• By Type of Breast Cancer

o Invasive
o Non-Invasive (in situ)

• By Diagnosis

o Blood Tests
o Mammogram
o Breast MRI
o Breast Ultrasound
o Breast Biopsy
o Others

• By Treatment

o Breast Cancer Surgery
o Radiation Therapy
o Chemotherapy
o ‘Hormone Therapy
o Targeted Therapy
o Supportive/ Palliative Care

• By Geography

o North America
o USA
o Canada
o Mexico
o Others
o South America
o Brazil
o Argentina
o Others
o Europe
o Germany
o France
o United Kingdom
o Spain
o Others
o Middle East and Africa
o Saudi Arabia
o Israel
o Others
o Asia Pacific
o China
o Japan
o South Korea
o India
o Others

---